Systemic responses during local viral infections: Type I IFNs sound the alarm

Current Opinion in Immunology

Volumn 23, Issue 4, 2011, Pages 495-499

  López, Carolina B ^a   Hermesh, Tamar ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR2; COLONY STIMULATING FACTOR; CXCL1 CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; INTERFERON; INTERLEUKIN 12; INTERLEUKIN 1BETA; LYMPHOTOXIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; RANTES; TUMOR NECROSIS FACTOR ALPHA;

CYTOKINE PRODUCTION; DENDRITIC CELL; EPSTEIN BARR VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOREGULATION; INFECTION SENSITIVITY; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MONOCYTE; MURINE HEPATITIS CORONAVIRUS; NONHUMAN; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; REVIEW; VACCINIA VIRUS; VIRUS CELL INTERACTION; VIRUS DETECTION; VIRUS INFECTION;

ADAPTIVE IMMUNITY; ANIMALS; BONE MARROW; CENTRAL NERVOUS SYSTEM; CYTOKINES; DENDRITIC CELLS; HEMATOPOIETIC STEM CELLS; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERFERON TYPE I; LYMPHATIC SYSTEM; MODELS, BIOLOGICAL; MONOCYTES; ORGAN SPECIFICITY; VIRUS DISEASES; VIRUS REPLICATION;

EID: 80052385268     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2011.06.003     Document Type: Review

References (52)

1. Carter C.C., Onafuwa-Nuga A., McNamara L.A., Riddell J., Bixby D., Savona M.R., Collins K.L. HIV-1 infects multipotent progenitor cells causing cell death and establishing latent cellular reservoirs. Nat Med 2010, 16:446-451.
2. Klco J.M., Geng B., Brunt E.M., Hassan A., Nguyen T.D., Kreisel F.H., Lisker-Melman M., Frater J.L. Bone marrow biopsy in patients with hepatitis C virus infection: spectrum of findings and diagnostic utility. Am J Hematol 2010, 85:106-110.
3. Hwang S., Wu T.T., Tong L.M., Kim K.S., Martinez-Guzman D., Colantonio A.D., Uittenbogaart C.H., Sun R. Persistent gammaherpesvirus replication and dynamic interaction with the host in vivo. J Virol 2008, 82:12498-12509.
4. Singh P., Yao Y., Weliver A., Broxmeyer H.E., Hong S.C., Chang C.H. Vaccinia virus infection modulates the hematopoietic cell compartments in the bone marrow. Stem Cells 2008, 26:1009-1016.
5. Navarini A.A., Recher M., Lang K.S., Georgiev P., Meury S., Bergthaler A., Flatz L., Bille J., Landmann R., Odermatt B., et al. Increased susceptibility to bacterial superinfection as a consequence of innate antiviral responses. Proc Natl Acad Sci USA 2006, 103:15535-15539.
6. Mueller S.N., Hosiawa-Meagher K.A., Konieczny B.T., Sullivan B.M., Bachmann M.F., Locksley R.M., Ahmed R., Matloubian M. Regulation of homeostatic chemokine expression and cell trafficking during immune responses. Science 2007, 317:670-674.
7. Lee L.N., Burke S., Montoya M., Borrow P. Multiple mechanisms contribute to impairment of type 1 interferon production during chronic lymphocytic choriomeningitis virus infection of mice. J Immunol 2009, 182:7178-7189.
8. Roth-Cross J.K., Bender S.J., Weiss S.R. Murine coronavirus mouse hepatitis virus is recognized by MDA5 and induces type I interferon in brain macrophages/microglia. J Virol 2008, 82:9829-9838.
9. Hermesh T., Moltedo B., Moran T.M., Lopez C.B. Antiviral instruction of bone marrow leukocytes during respiratory viral infections. Cell Host Microbe 2010, 7:343-353.
10. Zambon M.C. The pathogenesis of influenza in humans. Rev Med Virol 2001, 11:227-241.
11. Hermos C.R., Vargas S.O., McAdam A.J. Human metapneumovirus. Clin Lab Med 2010, 30:131-148.
12. Wilkins C., Gale M. Recognition of viruses by cytoplasmic sensors. Curr Opin Immunol 2010, 22:41-47.
13. Brennan K., Bowie A.G. Activation of host pattern recognition receptors by viruses. Curr Opin Microbiol 2010, 13:503-507.
14. Hayden F.G., Fritz R., Lobo M.C., Alvord W., Strober W., Straus S.E. Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. J Clin Invest 1998, 101:643-649.
15. Netea M.G., Kullberg B.J., Van der Meer J.W. Circulating cytokines as mediators of fever. Clin Infect Dis 2000, 31(Suppl. 5):S178-S184.
16. Dinarello C.A. Cytokines as endogenous pyrogens. J Infect Dis 1999, 179(Suppl. 2):S294-S304.
17. Versteeg G.A., Garcia-Sastre A. Viral tricks to grid-lock the type I interferon system. Curr Opin Microbiol 2010, 13:508-516.
18. Moltedo B., Lopez C.B., Pazos M., Becker M.I., Hermesh T., Moran T.M. Cutting edge: stealth influenza virus replication precedes the initiation of adaptive immunity. J Immunol 2009, 183:3569-3573.
19. Essers M.A.G., Offner S., Blanco-Bose W.E., Waibler Z., Kalinke U., Duchosal M.A., Trumpp A. IFNa activates dormant haematopoietic stem cells in vivo. Nature 2009, 458:904-908.
20. Sato T., Onai N., Yoshihara H., Arai F., Suda T., Ohteki T. Interferon regulatory factor-2 protects quiescent hematopoietic stem cells from type I interferon-dependent exhaustion. Nat Med 2009, 15:696-700.
21. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2814369/.
22. Baldridge M.T., King K.Y., Boles N.C., Weksberg D.C., Goodell M.A. Quiescent haematopoietic stem cells are activated by IFN-gamma in response to chronic infection. Nature 2010, 465:793-797.
23. Osterlund P., Veckman V., Siren J., Klucher K.M., Hiscott J., Matikainen S., Julkunen I. Gene expression and antiviral activity of alpha/beta interferons and interleukin-29 in virus-infected human myeloid dendritic cells. J Virol 2005, 79:9608-9617.
24. Phipps-Yonas H., Seto J., Sealfon S.C., Moran T.M., Fernandez-Sesma A. Interferon-beta pretreatment of conventional and plasmacytoid human dendritic cells enhances their activation by influenza virus. PLoS Pathog 2008, 4:e1000193.
25. Gerlini G., Mariotti G., Chiarugi A., Di Gennaro P., Caporale R., Parenti A., Cavone L., Tun-Kyi A., Prignano F., Saccardi R., et al. Induction of CD83+CD14+ nondendritic antigen-presenting cells by exposure of monocytes to IFN-alpha. J Immunol 2008, 181:2999-3008.
26. Kolumam G.A., Thomas S., Thompson L.J., Sprent J., Murali-Krishna K. Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J Exp Med 2005, 202:637-650.
27. Tough D.F., Borrow P., Sprent J. Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science 1996, 272:1947-1950.
28. Marrack P., Kappler J., Mitchell T. Type I interferons keep activated T cells alive. J Exp Med 1999, 189:521-530.
29. Coro E.S., Chang W.L., Baumgarth N. Type I IFN receptor signals directly stimulate local B cells early following influenza virus infection. J Immunol 2006, 176:4343-4351.
30. Swanson C.L., Wilson T.J., Strauch P., Colonna M., Pelanda R., Torres R.M. Type I IFN enhances follicular B cell contribution to the T cell-independent antibody response. J Exp Med 2010, 207:1485-1500.
31. Le Bon A., Schiavoni G., D'Agostino G., Gresser I., Belardelli F., Tough D.F. Type I interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity 2001, 14:461-470.
32. Alsharifi M., Lobigs M., Regner M., Lee E., Koskinen A., Mullbacher A. Type I interferons trigger systemic, partial lymphocyte activation in response to viral infection. J Immunol 2005, 175:4635-4640.
33. Ammann C.G., Messer R.J., Peterson K.E., Hasenkrug K.J. Lactate dehydrogenase-elevating virus induces systemic lymphocyte activation via TLR7-dependent IFNalpha responses by plasmacytoid dendritic cells. PLoS One 2009, 4:e6105.
34. Kohlmeier J.E., Cookenham T., Roberts A.D., Miller S.C., Woodland D.L. Type I interferons regulate cytolytic activity of memory CD8(+) T cells in the lung airways during respiratory virus challenge. Immunity 2010, 33:96-105.
35. Guarda G., Braun M., Staehli F., Tardivel A., Mattmann C., Forster I., Farlik M., Decker T., Du Pasquier R.A., Romero P., et al. Type I interferon inhibits interleukin-1 production and inflammasome activation. Immunity 2011, 34:213-223.
36. Sedger L.M., Hou S., Osvath S.R., Glaccum M.B., Peschon J.J., van Rooijen N., Hyland L. Bone marrow B cell apoptosis during in vivo influenza virus infection requires TNF-alpha and lymphotoxin-alpha. J Immunol 2002, 169:6193-6201.
37. Hennet T., Ziltener H.J., Frei K., Peterhans E. A kinetic study of immune mediators in the lungs of mice infected with influenza A virus. J Immunol 1992, 149:932-939.
38. Serbina N.V., Pamer E.G. Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat Immunol 2006, 7:311-317.
39. Tsou C.L., Peters W., Si Y., Slaymaker S., Aslanian A.M., Weisberg S.P., Mack M., Charo I.F. Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. J Clin Invest 2007, 117:902-909.
40. Si Y., Tsou C.-L., Croft K., Charo I.F. CCR2 mediates hematopoietic stem and progenitor cell trafficking to sites of inflammation in mice. J Clin Invest 2010, 120:1192-1203.
41. Seo S.U., Kwon H.J., Ko H.J., Byun Y.H., Seong B.L., Uematsu S., Akira S., Kweon M.N. Type I interferon signaling regulates Ly6C monocytes and neutrophils during acute viral pneumonia in mice. PLoS Pathog 2011, 7:e1001304.
42. Crane M.J., Hokeness-Antonelli K.L., Salazar-Mather T.P. Regulation of inflammatory monocyte/macrophage recruitment from the bone marrow during murine cytomegalovirus infection: role for type I interferons in localized induction of CCR2 ligands. J Immunol 2009, 183:2810-2817.
43. Jamieson A.M., Yu S., Annicelli C.H., Medzhitov R. Influenza virus-induced glucocorticoids compromise innate host defense against a secondary bacterial infection. Cell Host Microbe 2010, 7:103-114.
44. Swiecki M., Gilfillan S., Vermi W., Wang Y., Colonna M. Plasmacytoid dendritic cell ablation impacts early interferon responses and antiviral NK and CD8+ T cell accrual. Immunity 2010, 33:955-966.
45. Traynor T.R., Majde J.A., Bohnet S.G., Krueger J.M. Interferon type I receptor-deficient mice have altered disease symptoms in response to influenza virus. Brain Behav Immun 2007, 21:311-322.
46. Kurokawa M., Imakita M., Kumeda C.A., Shiraki K. Cascade of fever production in mice infected with influenza virus. J Med Virol 1996, 50:152-158.
47. Conn C.A., McClellan J.L., Maassab H.F., Smitka C.W., Majde J.A., Kluger M.J. Cytokines and the acute phase response to influenza virus in mice. Am J Physiol 1995, 268:R78-R84.
48. Basu S., Quilici C., Zhang H.H., Grail D., Dunn A.R. Mice lacking both G-CSF and IL-6 are more susceptible to Candida albicans infection: critical role of neutrophils in defense against Candida albicans. Growth Factors 2008, 26:23-34.
49. Longhi M.P., Wright K., Lauder S.N., Nowell M.A., Jones G.W., Godkin A.J., Jones S.A., Gallimore A.M. Interleukin-6 is crucial for recall of influenza-specific memory CD4 T cells. PLoS Pathog 2008, 4:e1000006.
50. Basu S., Hodgson G., Katz M., Dunn A.R. Evaluation of role of G-CSF in the production, survival, and release of neutrophils from bone marrow into circulation. Blood 2002, 100:854-861.
51. Liu F., Poursine-Laurent J., Link D.C. Expression of the G-CSF receptor on hematopoietic progenitor cells is not required for their mobilization by G-CSF. Blood 2000, 95:3025-3031.
52. Hubel K., Dale D.C., Liles W.C. Therapeutic use of cytokines to modulate phagocyte function for the treatment of infectious diseases: current status of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and interferon-gamma. J Infect Dis 2002, 185:1490-1501.